Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study

NACompletedINTERVENTIONAL
Enrollment

2,511

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

February 22, 2019

Study Completion Date

October 1, 2019

Conditions
Urinary Tract InfectionsProstatitisInterstitial Cystitis
Interventions
DIAGNOSTIC_TEST

Guidance 4.0 PCR test

All patients will have a urine culture and Guidance 4.0 PCR test run on their urine, but physicians will receive one or the other, or both depending on the treatment arm.

DIAGNOSTIC_TEST

Urine Culture

All patients will have a urine culture and Guidance 4.0 PCR test run on their urine, but physicians will receive one or the other, or both depending on the treatment arm.

Trial Locations (1)

48037

Comprehensive Urology, Royal Oak

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Comprehensive Urology-a Division of Michigan Healthcare Professionals

UNKNOWN

lead

Pathnostics

INDUSTRY

NCT03931538 - Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study | Biotech Hunter | Biotech Hunter